Latest Research

Merck’s PD-1 Inhibitor Pembrolizumab Subcutaneous Injection Approved in China

Merck, a pharmaceutical company based in Kenilworth, New Jersey, announced that its PD-1 inhibitor pembrolizumab…

Yiborui Releases AI Intelligent Agent Research Report: Consumer Willingness to Use Rises, Focus on “Authorization Management Mechanism”

Consumers are gradually applying AI intelligent agents to more complex financial service scenarios—beyond information retrieval…

Sino Group and SVhk Launch ‘Inno-North’ Initiative in Hong Kong

The northern urban area is gradually evolving into an important new community in Hong Kong's…

Track Investment Networks In China

Daily updated data and intelligence about the money and deals moving across Greater China!

Trusted By Global Partners

Extract Investment Insights

Streamed Daily

Since 2011, global funds, equity houses, and research firms have relied on China Money Network's primary data coverage.

Trustworthy

We provide last-mile news coverage of key alternative investment movements in China that you rely on for critical decisions.

Deep Focus

We can decipher the true from the dubious when investment news hits the airwaves, and we translate those discrepancies for you.

QUALITY

Companies like S&P Global, Morgan Stanley, and many others rely on our technology and services to enhance decision making.